Cheap gout drug tested as COVID-19 treatment
NCT ID NCT06847204
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study tested whether colchicine, an inexpensive anti-inflammatory drug usually used for gout, can help patients with mild to moderate COVID-19 pneumonia. 66 patients in Lahore were given the drug to see if it shortens hospital stays and reduces the need for oxygen. The goal was to find a low-cost treatment option for developing countries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
General hospital
Lahore, Punjab Province, Pakistan
Conditions
Explore the condition pages connected to this study.